About

Prof. Dr. Ahmed Ebied

Consultant Neurologist & Head of Neurology Department

Delivering evidence-based neurological care across the Gulf region for over two decades.

NMC Royal Hospital SharjahArabic & EnglishFEBN · PhD · MSc · MSCSAdjunct Professor — University of Sharjah

Two Decades of Neurological Excellence

Prof. Dr. Ahmed Ebied, MD, FEBN, PhD, MSCS, is a Board-Certified Consultant Neurologist and Head of the Neurology Department at NMC Royal Hospital Sharjah, and Adjunct Clinical Assistant Professor at the College of Medicine, University of Sharjah. With more than two decades of clinical, academic, and leadership experience spanning Egypt, Saudi Arabia, and the UAE, he is recognised as one of the region's leading authorities in headache medicine and neuroimmunology. He is a Board Member of the World Headache Society.

A Fellow of the European Board of Neurology with a PhD in Neurology from Zagazig University, Dr. Ebied subspecialises in headache medicine, neuroimmunology, and multiple sclerosis (MSCS-certified), with extensive experience in stroke and thrombolysis, epilepsy, and movement disorders. He established and led a multidisciplinary Headache Clinic from inception — with hands-on expertise in CGRP-targeted biologics (Aimovig, Emgality, Vyepti), ultrasound-guided Botulinum toxin, and therapeutic nerve blocks.

His research record includes 8 peer-reviewed publications and 4 multi-center randomized controlled trials in stroke, headache, and epilepsy (69 citations, h-index 6). Dr. Ebied is known for communicating complex neurological diagnoses with clarity and compassion in both Arabic and English, making him a trusted choice for patients throughout the UAE and broader Gulf region.

Professional Highlights

Fellow of the European Board of Neurology (FEBN)
PhD in Neurology — Zagazig University
Multiple Sclerosis Certified Specialist (MSCS, USA)
Board Member — World Headache Society
Adjunct Clinical Assistant Professor — University of Sharjah
UAE Golden Visa holder
Founded & led a multidisciplinary Headache Clinic
CGRP biologics (Aimovig, Emgality, Vyepti) & Botulinum toxin expert
Ultrasound-guided nerve blocks for headache disorders
Acute stroke, IV thrombolysis & neurocritical care
8 publications · 4 randomized controlled trials
Fluent Arabic & English speaker

Career Path

Professional Journey

2006

MB BCh — Zagazig University, Egypt

Medical degree followed by full neurology residency and MSc in Neuropsychiatry (2011) at Zagazig University Hospitals.

2011 – 2019

Lecturer & Staff Member — Zagazig University Hospitals

Senior faculty for undergraduate and postgraduate neurology teaching, MSc/PhD supervision, and clinical research — completing his PhD in Neurology (2019).

2012 – 2015

Specialist Neurologist — Saudi German Hospital, Jeddah

Neurology services in a major tertiary referral centre: stroke, epilepsy, movement disorders, and neuromuscular disease.

2019 – 2021

Specialist Neurologist — Saudi German Hospital, Sharjah

Outpatient, inpatient, critical care, and emergency neurology with multidisciplinary collaboration.

2022 – 2025

Consultant & Head of Neurology — Medcare Hospital, Sharjah

Led the Neurology Department and established a fully operational Headache Clinic with CGRP biologic, Botulinum toxin, and nerve block pathways.

2026

Master in Neuroimmunology — Universitat Autònoma de Barcelona (UAB), Spain

Master's Degree in Multiple Sclerosis and Immune-Mediated Neurological Disorders.

2026 – Present

Consultant Neurologist & Head of Neurology Department — NMC Royal Hospital Sharjah

Headache Clinic, MS Clinic, and Epilepsy Service, plus an active academic role as Adjunct Clinical Assistant Professor at the University of Sharjah.

Academic Work

Research & Publications

Stroke RCTs

Co-investigator on multi-center randomized controlled trials — including TICA-CLOP (CNS Drugs, 2025) and CILO-CLOP (Neurology and Therapy, 2025) — comparing antiplatelet strategies in acute ischemic stroke.

Headache & Migraine

Randomized multi-center trial of valproate versus topiramate in migraine prevention (Journal of Clinical Neuroscience, 2025), alongside clinical work on CGRP biologics and Botox protocols.

Epilepsy & Thrombolysis

Research on serum MMP-2 as an epilepsy biomarker and predictors of hemorrhagic transformation after stroke thrombolysis (Scientific Reports, 2025). 8 publications · 69 citations · h-index 6.

Schedule a Consultation

Consultations in Arabic & English at NMC Royal Hospital Sharjah. Book online, call, or WhatsApp.

Arabic & English consultations available